Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M, Sarkar R, Knop V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Fromm G, Lieb K, Baumert TF, Heinz A, Discher T, Neumann K, Zeuzem S, Berg T. Schaefer M, et al. Among authors: lieb k. Ann Intern Med. 2012 Jul 17;157(2):94-103. doi: 10.7326/0003-4819-157-2-201207170-00006. Ann Intern Med. 2012. PMID: 22801672 Free article. Clinical Trial.
Interferon alpha (IFNalpha) and psychiatric syndromes: a review.
Schaefer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K. Schaefer M, et al. Among authors: lieb k. Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):731-46. doi: 10.1016/s0278-5846(01)00324-4. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 12188106 Review.
Deep-brain stimulation for Parkinson's disease.
Lieb K, Schlaepfer TE. Lieb K, et al. N Engl J Med. 2006 Nov 23;355(21):2256; author reply 2256. doi: 10.1056/NEJMc062545. N Engl J Med. 2006. PMID: 17124028 No abstract available.
Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.
Tadić A, Gorbulev S, Dahmen N, Hiemke C, Braus DF, Röschke J, van Calker D, Wachtlin D, Kronfeld K, Gorbauch T, Seibert-Grafe M, Lieb K; EMC Study Group. Tadić A, et al. Among authors: lieb k. Trials. 2010 Feb 26;11:21. doi: 10.1186/1745-6215-11-21. Trials. 2010. PMID: 20187947 Free PMC article. Clinical Trial.
Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.
Tadić A, Wachtlin D, Berger M, Braus DF, van Calker D, Dahmen N, Dreimüller N, Engel A, Gorbulev S, Helmreich I, Kaiser AK, Kronfeld K, Schlicht KF, Tüscher O, Wagner S, Hiemke C, Lieb K. Tadić A, et al. Among authors: lieb k. Eur Neuropsychopharmacol. 2016 Apr;26(4):705-16. doi: 10.1016/j.euroneuro.2016.02.003. Epub 2016 Feb 9. Eur Neuropsychopharmacol. 2016. PMID: 26899588 Clinical Trial.
Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model.
Böge K, Karnouk C, Hahn E, Schneider F, Habel U, Banaschewski T, Meyer-Lindenberg A, Salize HJ, Kamp-Becker I, Padberg F, Hasan A, Falkai P, Rapp MA, Plener PL, Stamm T, Elnahrawy N, Lieb K, Heinz A, Bajbouj M. Böge K, et al. Among authors: lieb k. Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):95-106. doi: 10.1007/s00406-019-00991-5. Epub 2019 Feb 22. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 30796528
443 results